New drug combo tested for rare head and neck cancers
Disease control
Not yet recruiting
This study is testing whether an experimental drug called MRG003 works better alone or combined with another drug called putrelimab for people with advanced salivary gland cancer that has returned or spread. The trial will enroll 68 adults whose cancer has worsened despite previo…
Phase: PHASE2 • Sponsor: Ji Dongmei • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC